Louisiana Januvia Lawyers Explain Risks of Januvia

Louisiana Januvia Lawyer






(To view full size image, click the image or click here.)

The U.S. Food and Drug Administration (FDA) first approved Januvia for use in type 2 diabetes patients in October 2006. Manufactured and marketed by Merck & Co., Januvia was intended to help patients better manage their blood sugar levels. While the drug, similar to other medications, has successfully helped thousands of patients struggling with type 2 diabetes, several clinical trials have linked Januvia to an increased risk of pancreatitis, pancreatic cancer, thyroid cancer and other adverse health conditions. This is why patients are seeking counsel from Louisiana Januvia lawsuit attorneys.

Although each case is different, if you have sustained injuries or received a serious diagnosis from your healthcare provider and you feel that your condition is directly related to Januvia, contact a Louisiana Januvia lawyer today to learn more about your legal rights. You may be entitled to seek compensation for your health complications.

Known as an incretin mimetic because it mimics the function of incretin, Januvia is intended to help the pancreas to increase insulin production in type 2 diabetes patients. However, several clinical trials have suggested that Januvia may leave patients more prone to developing certain health conditions as it prevents the body from fighting off cancerous cells.

Plaintiffs are currently filing lawsuits throughout the U.S. against the manufacturer, claiming that Januvia caused liver cancer, pancreatitis, thyroid cancer, pancreatic cancer and kidney failure, among other complications. Patients have also reported stomach pain, confusion, drowsiness, nausea and fever. If you or a loved one have experienced one or more of these side effects, a Louisiana Januvia lawyer can help you to pursue a claim and potentially recover damages for your injuries.

The FDA has reportedly received 88 adverse event reports from patients who have been diagnosed with pancreatic cancer and pancreatitis. Additionally, a study published in 2013 suggested that Januvia patients were 25 times more likely to develop pancreatic cancer than those who opted for other type 2 diabetes medications. Of the 14,684 claims submitted to the FDA pertaining to Januvia, 765 were diagnosed with high blood sugar, 625 were diagnosed with pancreatitis and 1,942 had been hospitalized due to complications. A Louisiana Januvia lawyer can review your case if you or a loved one have suffered from adverse or life-threatening side effects while taking the medication.

Contact an Affiliated Louisiana Januvia Lawyer for More Information

Attorney Group for Louisiana is currently providing free, no-obligation consultations to those who feel that they have been injured by Januvia. Contact us today to learn whether you have a valid claim or if you have any questions or concerns pertaining to your use of the medication. We will connect you with an affiliated Louisiana Januvia lawyer if we feel you have a valid claim, and we will do our best to help you seek the compensation to which you may be entitled.